Healthcare / Diagnostics & ResearchUpdated 2026-05-10 22:07 UTC

MEDP stock hub

Medpace Holdings, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

MEDPis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

12.1B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

MEDP

In the news

Latest news · MEDP

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E24.5

P25 12.3P50 18.4P75 33.1

Trailing P/E26.7

P25 14.9P50 23.2P75 38.5

ROE77.3

P25 -105.6P50 -46.5P75 -3.1

ROIC475.6

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All MEDP market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

256

Groups with data

Currency

USD

Showing 256 of 256 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001668397
Company name	Medpace Holdings, Inc.
Country	United States
Country code	US
Cusip	58506Q109
Employees	6,200
Employees Change	300%
Employees Change Percent	5.08
Enterprise value	$11.6B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Diagnostics & Research
IPO Date	2016-08-11
Isin	US58506Q1094
Last refreshed	2026-05-10
Market cap	$12.1B
Market cap category	Large-Cap
Price	$424
Price currency	USD
Rev Per Employee	431,978.71x
Sector	Healthcare
Sic	8731
Symbol	MEDP
Website	https://www.medpace.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.8%
EV Earnings	25.2x
EV Sales Forward	4.05x
EV/EBIT	20.61x
EV/EBITDA	19.63x
EV/FCF	16.32x
EV/Sales	4.33x
FCF yield	5.87%
Forward P/E	24.53x
P/B ratio	20.24x
P/E ratio	26.66x
P/S ratio	4.52x
PE Ratio10 Y	39.58x
PE Ratio3 Y	30.06x
PE Ratio5 Y	29.96x
PEG ratio	1.81x
PS Forward	4.22x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	21.02%
EBITDA Margin	22.07%
FCF margin	26.55%
Gross margin	71.9%
Gross Profit	$1.9B
Gross Profit Growth	31.16%
Gross Profit Growth Q	33.51%
Gross Profit Growth3 Y	24.3%
Gross Profit Growth5 Y	26.78%
Net Income	$460.4M
Net Income Growth	10.57%
Net Income Growth Q	8.09%
Net Income Growth Quarters	17%
Net Income Growth Years	10%
Net Income Growth3 Y	21.49%
Net Income Growth5 Y	23.66%
Pretax Margin	21.35%
Profit Margin	17.19%
Profit Per Employee	$74,258
Profitable Years	10
ROA	17.47
Roa5y	12.99
ROCE	71.75
ROE	77.25
Roe5y	49.16
ROIC	475.6
Roic5y	87.79

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	41.37%
Cagr3y	27.04%
Cagr5y	20.74%
EPS Growth	21.48
EPS Growth Q	16.62
EPS Growth Quarters	17
EPS Growth Years	10
EPS Growth3 Y	26.43
EPS Growth5 Y	30.37
FCF Growth	31.44%
FCF Growth Q	25.15%
FCF Growth3 Y	22.72%
FCF Growth5 Y	24.83%
OCF Growth	27.01%
OCF Growth Q	20.62%
OCF Growth10 Y	22.94%
OCF Growth3 Y	20.56%
OCF Growth5 Y	22.6%
Revenue Growth	24.19x
Revenue Growth Q	26.5x
Revenue Growth Quarters	23x
Revenue Growth Years	10x
Revenue Growth3 Y	19.66x
Revenue Growth5 Y	22.9x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.33
Assets	$2.1B
Cash	$652.7M
Current Assets	$1.1B
Current Liabilities	$1.3B
Debt	$146.1M
Debt EBITDA	$0.23
Debt Equity	$0.24
Debt FCF	$0.21
Equity	$598.3M
Liabilities	$1.5B
Long Term Assets	$990.6M
Long Term Liabilities	$186.3M
Net Cash	$506.6M
Net Cash By Market Cap	$4.18
Net Cash Growth	74.03%
Net Debt EBITDA	$-0.86
Net Debt Equity	$-0.85
Net Debt FCF	$-0.71
Tangible Book Value	$-97.3M
Tangible Book Value Per Share	$-3.41
WACC	10.65

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.85
Net Working Capital	$-834.8M
Quick ratio	0.78
Working Capital	$-206M
Working Capital Turnover	$-10.57

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	8.94%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	41.34%
200-day SMA	513.8
3Y total return	105.04%
50-day SMA	465.3
50-day SMA vs 200-day SMA	50under200
5Y total return	156.53%
All Time High	628.9
All Time High Change	-32.58%
All Time High Date	2026-01-16
All Time Low	21.76
All Time Low Change	1,848.53%
All Time Low Date	2017-05-03
ATR	19.24
Beta	1.19
Beta1y	1.44
Beta2y	1.17
Ch YTD	-24.51
High	430.5
High52	628.9
High52 Date	2026-01-16
High52ch	-32.58%
Low	418
Low52	284.5
Low52 Date	2025-05-15
Low52ch	49.04%
Ma50ch	-8.88%
Price vs 200-day SMA	-17.48%
RSI	40.05
RSI Monthly	51.44
RSI Weekly	40.8
Sharpe ratio	0.74x
Sortino ratio	1.56
Total Return	8.94%
Tr YTD	-24.51
Tr1m	-16.62%
Tr1w	1.55%
Tr3m	-21.78%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	12
Analyst Count Top	3
Analyst Price Target Top	$567
Analyst Ratings	Hold
Analyst Ratings Top	Buy
Earnings EPS Estimate	$3.87
Earnings EPS Estimate Growth	5.45
Earnings Revenue Estimate	696,275,188x
Earnings Revenue Estimate Growth	24.65x
Operating Income	$562.9M
Operating Income Growth	23.36
Operating Income Growth Q	24.65
Operating Income Growth3 Y	23.25
Operating Income Growth5 Y	25.73
Operating margin	21.02
Price target	$473
Price Target Change	$11.6
Price Target Change Top	$33.65

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	22,996,450%
Float Percent	80.52%
Shares Insiders	19.42%
Shares Institutions	84.62%
Shares Out	28,559,689
Shares Qo Q	-0.01%
Shares Yo Y	-8.94%
Short Float	5.86%
Short Ratio	4.3
Short Shares	4.72

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$688.2M
Average Volume	502,123.5x
Bv Per Share	20.95
CAPEX	$-28.2M
Ch1m	-16.62
Ch1w	1.55
Ch1y	41.34
Ch3m	-21.78
Ch3y	105
Ch5y	156.5
Ch6m	-28.03
Change	-1.1%
Change From Open	-1.51
Close	428.7
Days Gap	0.42
Depreciation Amortization	28,100,000
Dollar Volume	123,597,696
Earnings Date	2026-04-22
Earnings Time	amc
EBIT	$562.9M
EBITDA	$591M
EPS	$15.9
F Score	7
FCF	$711M
FCF EV Yield	6.13x
FCF Per Share	$24.9
Financing CF	-501,752,000
Fiscal Year End	December
Founded	1,992
Goodwill	662,396,000
Graham Number	86.57593
Graham Upside	-79.58
Income Tax	$111.4M
Investing CF	-27,901,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-22
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-10
Lynch Fair Value	$376
Lynch Upside	-11.27
Ma150	527.5
Ma150ch	-19.63%
Ma20	457
Ma20ch	-7.22%
Net CF	211,245,000
Next Earnings Date	2026-07-20
Open	430.5
Optionable	Yes
P FCF Ratio	17.03
P OCF Ratio	16.38
Position In Range	47.79
Post Close	424
Postmarket Change Percent	-0.14
Postmarket Price	$423
Ppne	263,360,000
Price Date	2026-05-08
Price EBITDA	$20.49
Relative Volume	0.58x
Revenue	2,678,268,000x
SBC By Revenue	0.85x
Share Based Comp	22,812,000
Tax By Revenue	4.16x
Tax Rate	19.48%
Tr6m	-28.03%
Us State	Ohio
Volume	291,504
Z Score	6.84

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does MEDP pay a dividend?

Capital-return profile for this ticker.

Performance

MEDP stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns MEDP?

Insider, institutional, and short-interest positioning.

Institutional ownership

+84.6%

Float: +80.5% of shares outstanding

Insider ownership

+19.4%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

MEDP momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

40.0

Neutral momentum band

Price vs 200-day MA

-17.5%

50/200-day relationship not available

Beta (5Y)

1.19

Moves roughly with the market

Sharpe ratio

0.74

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About MEDP

Hub-level FAQ points readers to the deeper analysis pages.

What is the current MEDP stock rating?

Medpace Holdings, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full MEDP analysis?

The full report lives at /stocks/MEDP/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for MEDP?

The latest report frames MEDP around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the MEDP page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.